Avalon Ventures

Enlaza Therapeutics is a biotechnology research company founded in 2020 and based in La Jolla, California. The company focuses on developing novel protein therapeutics aimed at providing more effective and safer treatment options for patients. Utilizing advanced synthetic biology technology, Enlaza's platform enables site-specific covalent coupling driven by drug binding. This innovative approach allows for the creation of first-in-class covalent biologics, which are designed to offer enhanced efficacy and improved safety profiles compared to existing treatments.

Vocera Communications, Inc. specializes in providing secure and integrated communication and workflow solutions tailored for mobile workers across various sectors, including healthcare, hospitality, retail, energy, and education. The company’s offerings enhance communication and operational efficiency by integrating with existing clinical systems, such as electronic health records and nurse call systems. Vocera's product suite includes the Vocera Communication and Workflow System, which connects various communication devices, including hands-free and voice-controlled options, and the Vocera Care Experience software, designed to improve patient care quality and streamline manual tasks. Additionally, Vocera operates the Experience Innovation Network, collaborating with healthcare organizations to develop innovative solutions that improve patient and care team experiences. The company, founded in 2000 and headquartered in San Jose, California, serves approximately 1,700 healthcare facilities globally, including hospitals and clinics, and distributes its products through direct sales, resellers, and distributors.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Enlaza Therapeutics is a biotechnology research company founded in 2020 and based in La Jolla, California. The company focuses on developing novel protein therapeutics aimed at providing more effective and safer treatment options for patients. Utilizing advanced synthetic biology technology, Enlaza's platform enables site-specific covalent coupling driven by drug binding. This innovative approach allows for the creation of first-in-class covalent biologics, which are designed to offer enhanced efficacy and improved safety profiles compared to existing treatments.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Primer is an internet company that specializes in leveraging artificial intelligence to analyze extensive collections of text data. Its machine intelligence platform employs advanced machine learning and natural language processing techniques to automate the analysis of large datasets. By parsing and collating documents in multiple languages, Primer enables businesses to uncover insights and generate reports that are on par with human analysts. This capability helps organizations bridge the intelligence gap and respond more effectively to emerging trends in their respective fields.

Fortis Therapeutics is a biotechnology company specializing in immuno-oncology, dedicated to developing innovative antibody-drug conjugate therapies targeting CD46. The company focuses on treating late-stage multiple myeloma and prostate cancer, among other indications. Its platform is designed to advance therapies for both adenocarcinoma and neuroendocrine cancers, providing healthcare professionals with effective treatment options for patients facing these advanced stages of cancer.

Janux Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies aimed at generating immune responses to combat tumors while preserving healthy tissue. Utilizing its proprietary tumor-activated T Cell Engager platform technology, Janux targets all three stages of the anti-tumor immune response. The company's approach is designed to enhance the efficacy of cancer treatments by specifically engaging the immune system to identify and eliminate cancer cells.

Pando has developed a financial platform aimed at individuals in high-volatility careers, such as professional athletes, entrepreneurs, and MBA graduates. The platform enables users to connect with others who have similar expected earnings, allowing them to pool a fraction of their future income. This innovative approach not only helps mitigate financial risks associated with unpredictable income but also allows participants to benefit from potential upside. By providing these tools, Pando empowers its clients to better manage their financial futures and protect their earnings.

Figg is a card-linked marketing company that provides a digital advertising platform designed to enhance value through everyday transactions. Its unique platform enables brands to market effectively within a private marketplace that includes banks and publishers. By partnering with these financial institutions and publishers, Figg offers advertiser-funded promotions to consumers, fostering loyalty and engagement. The platform allows consumers to enroll any credit or debit card, facilitating incremental cash-back rewards through targeted offers. With access to powerful transaction data, Figg enables advertisers to reach specific consumer segments with precise targeting and accurate tracking of marketing expenditures, benefiting both businesses and consumers alike.

Orion Labs, Inc. offers a voice communication and workflow platform designed for mobile and frontline teams, facilitating secure voice, location, and data messaging across a variety of connected devices and applications. Its product suite includes a Push to Talk app, web-based command center, advanced location services, language translation, and various AI-powered workflows. The platform is compatible with traditional VoIP and Land Mobile Radio systems, and it provides APIs and SDKs for developers to extend its functionalities. Orion Labs serves multiple industries, including hospitality, field services, transportation, and healthcare, selling its solutions primarily online in the United States and Canada. Founded in 2013 and headquartered in San Francisco, the company, originally named OnBeep, was rebranded in 2015 and has since formed strategic alliances with organizations such as ResponderXLabs and the FirstNet Association.

AristaMD is a digital health company based in La Jolla, California, founded in 2013. It specializes in enhancing the specialty referral process through its eConsult platform. This platform equips primary care providers with clinical workup checklists and enables electronic consultations with specialists. AristaMD's solution allows payers and providers to initiate specialist eConsults using their own specialists or those from AristaMD’s board-certified panel. The platform facilitates the transmission of patient clinical notes, history, lab results, and images, fostering collaboration on care plans within hours. This approach aims to improve patient outcomes by providing timely access to specialty care and reducing referral wait times.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

Seva is a cloud-based information discovery and collaboration platform founded in late 2017 and launched in mid-2018, based in New York City. The company focuses on enhancing workplace efficiency by providing teams with a centralized source of information that integrates various applications, including email, messaging, and document management. By serving as a "digital teammate," Seva streamlines the process of finding information, allowing knowledge workers to access crucial data quickly and effectively, thereby minimizing time spent searching through documents. This approach empowers users to work smarter and faster within the modern work environment.

Joy Life, Inc. is a San Francisco-based company that offers a comprehensive wedding planning portal and application designed to assist users from engagement through to their honeymoon. Founded in 2014, Joy's platform provides tools for organizing wedding details, including customizable checklists, wedding websites, and mobile applications. Users can manage guest lists, send digital or printed invitations, track RSVPs, and link gift registries. The application also fosters interaction among wedding guests by allowing photo sharing and comments on a private timeline. Additionally, Joy offers features for sending custom notifications and messages, enabling a seamless planning experience for couples and their wedding parties.

Memrise is a language learning platform accessible on iOS, Android, and the web, offering over 150 courses in 25 languages. With more than 40 million registered users, the platform provides a free learning experience without advertisements. Memrise employs innovative teaching methods, utilizing images, science, and flashcards to enhance vocabulary acquisition and language comprehension. While the basic courses are free, users can unlock additional features and learning modes through a Memrise Pro subscription. Since late 2016, Memrise has maintained profitability, reflecting its successful approach to language education.

BotChain enables universal registration, identity validation, audit, and coordination of A.I. agents and autonomous software. The BotChain was created by the team at Talla. After more than two years of building intelligent, AI-driven bots for the enterprise, Talla began pursuing their idea for BotChain. The leadership team represents decades of experience in software development, Artificial Intelligence, startups, and innovation.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Averon US, Inc. specializes in mobile identity verification technology, focusing on its Direct Autonomous Authentication (DAA) standard. This innovative approach allows smartphone users to securely interact with a variety of services, such as banking, e-commerce, and smart locks, without the need for dedicated applications or software installations. By utilizing real-time mobile network signaling and SIM/eSIM chips, Averon provides seamless authentication that requires no user involvement, ensuring both privacy and security. Founded in 2015 and based in San Francisco, the company is committed to enhancing online identity verification while eliminating reliance on personally identifiable information. Supported by 35 patents, Averon's technology is adopted by leading firms in various sectors, including transportation and digital currency, creating a streamlined and secure user experience.

Pando has developed a financial platform aimed at individuals in high-volatility careers, such as professional athletes, entrepreneurs, and MBA graduates. The platform enables users to connect with others who have similar expected earnings, allowing them to pool a fraction of their future income. This innovative approach not only helps mitigate financial risks associated with unpredictable income but also allows participants to benefit from potential upside. By providing these tools, Pando empowers its clients to better manage their financial futures and protect their earnings.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Averon US, Inc. specializes in mobile identity verification technology, focusing on its Direct Autonomous Authentication (DAA) standard. This innovative approach allows smartphone users to securely interact with a variety of services, such as banking, e-commerce, and smart locks, without the need for dedicated applications or software installations. By utilizing real-time mobile network signaling and SIM/eSIM chips, Averon provides seamless authentication that requires no user involvement, ensuring both privacy and security. Founded in 2015 and based in San Francisco, the company is committed to enhancing online identity verification while eliminating reliance on personally identifiable information. Supported by 35 patents, Averon's technology is adopted by leading firms in various sectors, including transportation and digital currency, creating a streamlined and secure user experience.

Talla, Inc., founded in 2015 and based in Brookline, Massachusetts, specializes in developing an AI and automation platform aimed at enhancing customer support services. The company offers a comprehensive IT Service Management (ITSM) solution that automates support workflows, allowing users to efficiently access accurate answers to inquiries while simultaneously boosting customer satisfaction and support team productivity. Talla's platform is designed to manage and prioritize requests, automate responses to frequently asked questions, and provide proactive employee education, all within chat applications. Unlike its competitors, Talla's technology improves over time through machine learning and seamlessly integrates with various tools essential for support teams.

Nanonets is an AI-driven company specializing in automating document processing and data extraction workflows. By utilizing advanced Optical Character Recognition (OCR) and deep learning models, Nanonets assists businesses in managing document-intensive processes such as accounts payable, order processing, and insurance underwriting. The platform effectively processes unstructured documents—such as invoices, receipts, and contracts—transforming them into structured data. Nanonets integrates seamlessly with existing systems through APIs, significantly reducing manual effort by up to 90% while delivering high accuracy and efficiency. The solution not only enhances productivity but also offers substantial cost savings, making it a valuable tool for organizations looking to streamline their operations without the need for complex database management.

Smyte Inc. is a Software-as-a-Service company that offers trust and safety solutions for websites and mobile applications. Founded in 2014 and based in San Francisco, Smyte employs a combination of manual heuristics, machine learning, and proprietary reputation data to assist businesses in proactively combating spam, fraud, bots, phishing, harassment, and account takeovers. The company's technology is designed to scale to complex trust and safety challenges, processing nearly five billion online actions each month. Smyte integrates its code into client platforms, allowing it to monitor user interactions and identify potentially harmful activities through an automated labeling system. This system flags suspicious behavior for manual review, enabling enterprises, marketplaces, and social networks to enhance security and maintain user trust. Smyte operates as a subsidiary of Twitter.

Piper Networks specializes in developing advanced tracking solutions for transportation and workforce management, focusing on real-time location awareness in complex environments. Utilizing technologies such as Ultra-Wideband (UWB) and Bluetooth Low Energy (BLE), Piper's proprietary proximity solutions deliver superior accuracy, achieving location precision within 10 centimeters while minimizing signal latency and interference. Their platform not only facilitates reliable wireless communication in challenging settings, such as underground subway tunnels, but also supports a variety of applications including messaging, data capture, and contextual information delivery to users. With a robust content dashboard, clients can create engaging communication options that enhance customer engagement and provide valuable analytics for inventory tracking.

Fortis Therapeutics is a biotechnology company specializing in immuno-oncology, dedicated to developing innovative antibody-drug conjugate therapies targeting CD46. The company focuses on treating late-stage multiple myeloma and prostate cancer, among other indications. Its platform is designed to advance therapies for both adenocarcinoma and neuroendocrine cancers, providing healthcare professionals with effective treatment options for patients facing these advanced stages of cancer.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

AristaMD is a digital health company based in La Jolla, California, founded in 2013. It specializes in enhancing the specialty referral process through its eConsult platform. This platform equips primary care providers with clinical workup checklists and enables electronic consultations with specialists. AristaMD's solution allows payers and providers to initiate specialist eConsults using their own specialists or those from AristaMD’s board-certified panel. The platform facilitates the transmission of patient clinical notes, history, lab results, and images, fostering collaboration on care plans within hours. This approach aims to improve patient outcomes by providing timely access to specialty care and reducing referral wait times.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Node, recently acquired by SugarCRM, fuels Sugar's time-aware CX platform to help businesses by automatically forecasting expected outcomes and highlighting previously unforeseen challenges and opportunities. Extending Sugar’s time-aware CX platform, Node’s AI technology adds the most coveted element of time—the future. The combined solution offers wide-ranging capabilities for sales, marketing, and service teams. Node enables users of business applications to see into the future. Powered by Artificial Intuition™ technology, Node is the first turnkey AI-as-a-service platform focused on powering predictable business outcomes, which enterprises can use to quickly and seamlessly build advanced AI into both customer-facing and internal applications without investing years and millions of dollars on risky AI experiments. Applications powered by Node can deliver predictions that enable users to make smarter connections and decisions about how to engage with customers, employees, investors, and partners. Node was founded by Google's youngest employee, Falon Fatemi, and it's renowned technology team includes the Godfather of Search, Louis Monier who created Alta Vista, and Michael Radovancevich former CTO of Taleo and OpenX. Node is backed by Mark Cuban, NEA, Avalon Ventures, and JetBlue Technology Ventures.

Orion Labs, Inc. offers a voice communication and workflow platform designed for mobile and frontline teams, facilitating secure voice, location, and data messaging across a variety of connected devices and applications. Its product suite includes a Push to Talk app, web-based command center, advanced location services, language translation, and various AI-powered workflows. The platform is compatible with traditional VoIP and Land Mobile Radio systems, and it provides APIs and SDKs for developers to extend its functionalities. Orion Labs serves multiple industries, including hospitality, field services, transportation, and healthcare, selling its solutions primarily online in the United States and Canada. Founded in 2013 and headquartered in San Francisco, the company, originally named OnBeep, was rebranded in 2015 and has since formed strategic alliances with organizations such as ResponderXLabs and the FirstNet Association.

AlphaSheets is a Boston-based company that offers cloud-based programmable spreadsheet solutions tailored for financial analytics, business intelligence, risk management, and bioinformatics. Its primary product, AlphaSheets, aims to address the limitations of traditional spreadsheets in enterprise settings by providing an intuitive and visually appealing interface. The platform allows users to import data and functions from diverse sources, facilitating comprehensive analysis and visualization across various applications. Through its innovative approach, AlphaSheets seeks to enhance the usability and efficiency of spreadsheet tools for professionals.

Enlibrium is developing novel drugs based on metformin to treat a range of different cancers by reducing cancer energy consumption and reestablishing energy balance. Given their high growth rate and energy requirements, cancers are particularly sensitive to agents that reduce their energy production. Enlibrium was founded based on technology exclusively licensed from UCLA and developed in laboratories headed by Michael Jung, Ph.D. and Richard Pietras, M.D., Ph.D. Enlibrium's investors are Avalon Ventures, TPG Biotech, Correlation Ventures and Osage University Partners.

Skycatch, Inc. is a technology company based in San Francisco, California, that specializes in aerial data capture and analytics, primarily for the construction and mining industries. The company designs and produces the Evolution3 drone, which enables real-time data capture and 3D rendering. Skycatch also offers a proprietary app called Commander for drone operation, along with Dashboard software that analyzes collected data and facilitates team collaboration. Their platform combines advanced hardware, software, and artificial intelligence to provide clients with high-precision data quickly and efficiently. Founded in 2013, Skycatch focuses on indexing and extracting critical information from the physical world, helping enterprises visualize their environments with accuracy and ease.

MOGL is a restaurant rewards application dedicated to combating hunger in the United States. Members can earn 10% cash-back at thousands of participating restaurants by using a linked credit or debit card for their payments. Shortly after making a purchase, members receive an alert that allows them to donate a portion or the entirety of their cash-back to a local food bank. The app features a Hunger Tracker, enabling users to monitor the impact of their donations in their communities and engage in friendly competition with friends to see who can contribute the most meals. Founded in 2010, MOGL is headquartered in Solana Beach, California.

Empyr, Inc. is an online-to-offline advertisement platform based in San Diego, California, that connects publishers and advertisers by tracking online advertisements to offline purchases in real-time. Founded in 2011, the company specializes in card-linked offers, allowing consumers to earn cashback at offline merchants simply by using their debit or credit cards. This seamless integration taps into a significant market opportunity, as a substantial amount of offline commerce driven by online and mobile channels remains untracked and unmonetized. Empyr collaborates with major corporations, including tech companies, banks, airlines, and hotels, to facilitate these commerce programs. Its partnerships extend to over 1,500 affiliates, including notable names like Microsoft and LivingSocial. By enabling merchants to link online marketing efforts directly to actual offline sales, Empyr provides a valuable service in the evolving landscape of digital commerce. The company has raised $35 million through its parent company, Mogl, and employs around 60 staff members.

AeroFS offers an enterprise file synchronization and collaboration platform aimed at enhancing the way creative agencies, consultants, freelancers, and teams work together. Its flagship product, Amium, facilitates more intuitive and efficient sharing of information and ideas, significantly improving collaboration across organizational boundaries. The platform operates on a private cloud-like infrastructure, allowing clients to store data on designated devices while maintaining the ability to run entirely behind firewalls, including authentication measures. AeroFS prioritizes user privacy, control, and scalability, ensuring that both administrators and end-users benefit from a secure and streamlined collaboration experience. The company continuously updates its software, providing users with the latest features and improvements to enhance their collaborative efforts.

Ankasa Regenerative Therapeutics is a biopharmaceutical company focused on advancing tissue healing by harnessing the capabilities of stem cell reactivation. Established in 2014 and based in La Jolla, California, the company is developing proprietary formulations of a WNT stem cell activator aimed at accelerating tissue repair across various degenerative conditions, including those affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its innovative approach has shown promise in enhancing the osteogenic properties of patient-derived stem cells, particularly in reconstructive surgeries, thereby improving bone formation and reducing the need for revision surgeries and their associated complications. The company's preclinical models indicate that its therapies may offer superior outcomes for bone reformation compared to existing standards of care.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Vook, now known as Pronoun, is a publishing firm that focuses on both digital and print formats. The company specializes in ebook creation, distribution, cover design, and copy editing services. By leveraging technology and data, Vook aims to empower authors, enabling them to publish their works more efficiently while maintaining both creative and financial control. The firm seeks to enhance the publishing process, allowing authors to market their books effectively and connect with their audiences.

Calporta is developing selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases. Mutations that cause NPC lead to impaired intracellular lipid trafficking and lead to lysosomal accumulation of cholesterol and biolipds. TRPML1 is an ion channel in the lysosome and a key regulator of lysosomal trafficking processes. Impaired TRPML1 function has been implicated in multiple pathological conditions, including NPC. Agonists of TRPML1 restore calcium efflux and normalize lysosomal trafficking and function. In addition to NPC and other lysosomal storage diseases, agonists of TRPML1 may have broad potential in other diseases such as muscular dystrophy and various taopathies such as Alzheimer's disease. Calporta's approach is based on research from the lab of Haoxing Xu, Ph.D., at the University of Michigan.

Cadherx Therapeutics develops therapeutic antibodies targeting soluble E-cadherin.

BookBub is a rapidly growing startup launched by serial entrepreneurs and run by a team gathered from the publishing and tech industries. Every day millions of readers use our service to discover great books, and thousands of leading publishers and authors work with us to drive sales and find new fans. Connecting readers with great deals on ebooks is just the beginning for BookBub. The rise of digital publishing is altering the way books are found, purchased, and read. We’re expanding our team to help address the challenges and opportunities of the publishing industry while continuing to help readers find books and authors they’ll love.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Cardeas Pharma is focused on developing a novel antibiotic formulation that combines two drugs to effectively target highly resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, as well as carbapenem-resistant Enterobacteriaceae. This formulation is also effective against biofilms and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The antibiotics are delivered through a single-patient use nebulizer that produces small, uniform aerosol droplets, allowing for targeted delivery to the small airways and alveoli. By integrating this innovative antibiotic formulation with advanced drug-delivery technology, Cardeas Pharma aims to improve clinical outcomes for patients suffering from serious, hospital-acquired respiratory infections.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Nanigans is a Boston-based company that specializes in advertising automation software, designed to support in-house performance marketing teams. As a Software-as-a-Service provider, Nanigans offers a platform that features programmatic media buying, predictive revenue optimization, and real-time business intelligence. This comprehensive approach allows clients to enhance their advertising strategies and optimize revenue generation across various digital channels. In addition to its headquarters in Boston, Nanigans has established offices in New York, San Francisco, Seattle, London, Sydney, and Singapore, reflecting its global reach and commitment to serving a diverse client base.

Primer is an internet company that specializes in leveraging artificial intelligence to analyze extensive collections of text data. Its machine intelligence platform employs advanced machine learning and natural language processing techniques to automate the analysis of large datasets. By parsing and collating documents in multiple languages, Primer enables businesses to uncover insights and generate reports that are on par with human analysts. This capability helps organizations bridge the intelligence gap and respond more effectively to emerging trends in their respective fields.

StackRox, Inc. develops a Kubernetes-native container security platform that helps enterprises secure their cloud-native applications throughout the entire life cycle, from build to deploy to runtime. The platform offers deep visibility into container and microservice activity, enabling users to discover and categorize assets effectively. It protects cloud workloads by detecting various cyber threats, including code injection and privilege escalation, while orchestrating threat responses through policy-driven workflows. StackRox integrates seamlessly with existing DevOps and security tools, allowing teams to operationalize security measures efficiently. The company serves a diverse clientele, including cloud-native organizations, Global 2000 enterprises, and government agencies. Founded in 2014, StackRox is headquartered in Mountain View, California.

Primer is an internet company that specializes in leveraging artificial intelligence to analyze extensive collections of text data. Its machine intelligence platform employs advanced machine learning and natural language processing techniques to automate the analysis of large datasets. By parsing and collating documents in multiple languages, Primer enables businesses to uncover insights and generate reports that are on par with human analysts. This capability helps organizations bridge the intelligence gap and respond more effectively to emerging trends in their respective fields.

Conjur offers a DevOps security software platform that helps organizations secure their cloud environments while automating infrastructure processes. The platform focuses on identity and access management, enabling enterprises to identify, authorize, and audit all service and user identities across various systems, including cloud services, virtual machines, and containers. By addressing operational, compliance, and security challenges, Conjur allows customers to protect sensitive IT systems and monitor access in real-time. The software enforces security policies, reduces vulnerability points, and generates detailed activity reports for compliance and security audits. As organizations increasingly adopt cloud computing, Conjur provides essential tools for security-conscious enterprises to deploy sensitive workloads confidently. Its notable clientele includes companies such as Discovery Communications, AOL, and Cisco. Conjur is backed by seed funding from investment firms like Avalon Partners and Amplify Partners.

Redbooth is a cloud-based task and project management platform that facilitates team collaboration by offering a centralized space for shared tasks, discussions, and file sharing. Founded in 2008 and headquartered in Palo Alto, California, the platform is designed to enhance productivity through features such as project management templates, real-time communication, and integration with various tools like Slack, Outlook, and Dropbox. Redbooth serves a diverse range of sectors, including marketing, finance, education, and legal services, and is utilized by over 400,000 organizations worldwide, including notable companies and institutions such as AT&T, BBC, and Harvard University. The platform is accessible on mobile, desktop, and smart devices, making it adaptable for remote and in-office teams.

MOGL is a restaurant rewards application dedicated to combating hunger in the United States. Members can earn 10% cash-back at thousands of participating restaurants by using a linked credit or debit card for their payments. Shortly after making a purchase, members receive an alert that allows them to donate a portion or the entirety of their cash-back to a local food bank. The app features a Hunger Tracker, enabling users to monitor the impact of their donations in their communities and engage in friendly competition with friends to see who can contribute the most meals. Founded in 2010, MOGL is headquartered in Solana Beach, California.

Empyr, Inc. is an online-to-offline advertisement platform based in San Diego, California, that connects publishers and advertisers by tracking online advertisements to offline purchases in real-time. Founded in 2011, the company specializes in card-linked offers, allowing consumers to earn cashback at offline merchants simply by using their debit or credit cards. This seamless integration taps into a significant market opportunity, as a substantial amount of offline commerce driven by online and mobile channels remains untracked and unmonetized. Empyr collaborates with major corporations, including tech companies, banks, airlines, and hotels, to facilitate these commerce programs. Its partnerships extend to over 1,500 affiliates, including notable names like Microsoft and LivingSocial. By enabling merchants to link online marketing efforts directly to actual offline sales, Empyr provides a valuable service in the evolving landscape of digital commerce. The company has raised $35 million through its parent company, Mogl, and employs around 60 staff members.

StackIQ, Inc. is a technology company that specializes in server automation and infrastructure management. Founded in 2006 and based in Solana Beach, California, the company offers a software suite that automates the deployment and management of bare metal environments for various applications, including big data and private cloud automation. Its flagship product, Stacki, is an open-source Linux server provisioning tool that transforms bare hardware into fully operational clusters by handling tasks such as operating system installation, network configuration, and RAID setup. Additionally, StackIQ has developed Stacki Ace, which extends these capabilities to Raspberry Pi devices, and Stacki Pro, which supports the installation of SUSE Linux Enterprise Server and multiple distributions from a single interface. In 2011, the company changed its name from Clustercorp, Inc. and, as of 2017, operates as a subsidiary of Teradata Corporation.

Kinvey, Inc. offers a mobile backend as a service (mBaaS) platform designed to simplify the development of cloud backends for mobile, tablet, and web applications. Established in 2008 and based in Boston, Massachusetts, Kinvey enables developers to focus exclusively on application development without the burden of managing server infrastructure or integrating various cloud services. The platform provides automated API generation, allowing developers to seamlessly connect their applications to backend services. Kinvey's solutions cater to a diverse range of industries, including healthcare, finance, utilities, and media, facilitating features such as data storage, user management, push notifications, and analytics. As of June 2017, Kinvey operates as a subsidiary of Progress Software Corporation.

Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulates the iron supply for red blood cell production. Iron deficiency, also known as anemia, is a condition in which blood does not contain the normal amount of red blood cells or lacks the proper amount of hemoglobin. This, in turn, lowers the amount of oxygen-rich blood in circulation, causing shortness of breath, dizziness or headaches.

Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production. The same antibodies stimulate the tissue around the eyes, resulting in an increase of orbital fat and extra-ocular muscle volume which causes the bulging of the eyes characteristic of Graves' orbitopathy.

Sidecar Technologies provides B2B delivery transportation network in the world. It is building the world's most convenient and affordable transportation network created for and powered by everyday people. All drivers are pre-vetted for safety and are free to give rides whenever they want. Sidecar safety system includes driver background checks, driver and rider rating systems, GPS tracking features, and the ability to share details of your trip in real-time. Sidecar was founded in San Francisco in 2011 and currently operates in ten cities and has facilitated more than half a million rides.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Skycatch, Inc. is a technology company based in San Francisco, California, that specializes in aerial data capture and analytics, primarily for the construction and mining industries. The company designs and produces the Evolution3 drone, which enables real-time data capture and 3D rendering. Skycatch also offers a proprietary app called Commander for drone operation, along with Dashboard software that analyzes collected data and facilitates team collaboration. Their platform combines advanced hardware, software, and artificial intelligence to provide clients with high-precision data quickly and efficiently. Founded in 2013, Skycatch focuses on indexing and extracting critical information from the physical world, helping enterprises visualize their environments with accuracy and ease.

BookBub is a rapidly growing startup launched by serial entrepreneurs and run by a team gathered from the publishing and tech industries. Every day millions of readers use our service to discover great books, and thousands of leading publishers and authors work with us to drive sales and find new fans. Connecting readers with great deals on ebooks is just the beginning for BookBub. The rise of digital publishing is altering the way books are found, purchased, and read. We’re expanding our team to help address the challenges and opportunities of the publishing industry while continuing to help readers find books and authors they’ll love.

Otonomy, Inc. is a biopharmaceutical company based in San Diego, California, that specializes in developing therapeutics for ear disorders. The company markets OTIPRIO, a ciprofloxacin otic suspension used during tympanostomy tube placement surgery in pediatric patients. Otonomy is advancing several product candidates, including OTIVIDEX, a sustained-exposure formulation of dexamethasone for Ménière’s disease; OTO-313, a formulation for tinnitus in Phase I/II trials; and OTO-413, aimed at repairing cochlear synaptopathy and addressing speech-in-noise hearing difficulties. Additionally, the company is developing OTO-510, designed to prevent cisplatin-induced hearing loss, and OTO-6XX, which focuses on hair cell regeneration for severe hearing loss. Otonomy employs a proprietary formulation platform that enables sustained drug delivery from a single administration, enhancing treatment options for various ear-related conditions. The company also has strategic collaborations for gene therapy aimed at congenital hearing loss. Founded in 2008, Otonomy continues to lead advancements in otology through innovation and research.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Sidecar Technologies provides B2B delivery transportation network in the world. It is building the world's most convenient and affordable transportation network created for and powered by everyday people. All drivers are pre-vetted for safety and are free to give rides whenever they want. Sidecar safety system includes driver background checks, driver and rider rating systems, GPS tracking features, and the ability to share details of your trip in real-time. Sidecar was founded in San Francisco in 2011 and currently operates in ten cities and has facilitated more than half a million rides.

Empyr, Inc. is an online-to-offline advertisement platform based in San Diego, California, that connects publishers and advertisers by tracking online advertisements to offline purchases in real-time. Founded in 2011, the company specializes in card-linked offers, allowing consumers to earn cashback at offline merchants simply by using their debit or credit cards. This seamless integration taps into a significant market opportunity, as a substantial amount of offline commerce driven by online and mobile channels remains untracked and unmonetized. Empyr collaborates with major corporations, including tech companies, banks, airlines, and hotels, to facilitate these commerce programs. Its partnerships extend to over 1,500 affiliates, including notable names like Microsoft and LivingSocial. By enabling merchants to link online marketing efforts directly to actual offline sales, Empyr provides a valuable service in the evolving landscape of digital commerce. The company has raised $35 million through its parent company, Mogl, and employs around 60 staff members.

MOGL is a restaurant rewards application dedicated to combating hunger in the United States. Members can earn 10% cash-back at thousands of participating restaurants by using a linked credit or debit card for their payments. Shortly after making a purchase, members receive an alert that allows them to donate a portion or the entirety of their cash-back to a local food bank. The app features a Hunger Tracker, enabling users to monitor the impact of their donations in their communities and engage in friendly competition with friends to see who can contribute the most meals. Founded in 2010, MOGL is headquartered in Solana Beach, California.

Quippi Corporation is an international shopping card company based in La Jolla, California, that offers a fee-free alternative to traditional money transfer services. Established in 2012, it specializes in international gift cards purchased in the United States and redeemable in Mexico at leading retailers. Quippi’s unique model allows customers to buy a gift card online or in-store and send a PIN code to recipients in Mexico, enabling them to shop immediately without any fees or hidden charges. The gift cards can be used at seven retail partners in Mexico, covering a range of products such as groceries, clothing, appliances, and health services. Quippi aims to expand its network of retail partners in Mexico and plans to extend its services throughout Latin America and beyond. As of October 2015, it operates as a subsidiary of EMIDA Technologies, Inc.

Chartio is a cloud-based data exploration platform aimed at democratizing data access and analysis. Founded in June 2010 and based in San Francisco, the company provides an intuitive solution that enables users to connect various data sources and create dynamic dashboards without requiring SQL knowledge. With its drag-and-drop interface and robust data pipeline, Chartio facilitates real-time querying, analysis, and tracking of key metrics, allowing businesses to easily identify trends, patterns, and anomalies in their data. By bypassing the need for data warehousing, Chartio helps organizations optimize decision-making and leverage complex data to drive growth while addressing security concerns.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.

Redbooth is a cloud-based task and project management platform that facilitates team collaboration by offering a centralized space for shared tasks, discussions, and file sharing. Founded in 2008 and headquartered in Palo Alto, California, the platform is designed to enhance productivity through features such as project management templates, real-time communication, and integration with various tools like Slack, Outlook, and Dropbox. Redbooth serves a diverse range of sectors, including marketing, finance, education, and legal services, and is utilized by over 400,000 organizations worldwide, including notable companies and institutions such as AT&T, BBC, and Harvard University. The platform is accessible on mobile, desktop, and smart devices, making it adaptable for remote and in-office teams.

Otonomy, Inc. is a biopharmaceutical company based in San Diego, California, that specializes in developing therapeutics for ear disorders. The company markets OTIPRIO, a ciprofloxacin otic suspension used during tympanostomy tube placement surgery in pediatric patients. Otonomy is advancing several product candidates, including OTIVIDEX, a sustained-exposure formulation of dexamethasone for Ménière’s disease; OTO-313, a formulation for tinnitus in Phase I/II trials; and OTO-413, aimed at repairing cochlear synaptopathy and addressing speech-in-noise hearing difficulties. Additionally, the company is developing OTO-510, designed to prevent cisplatin-induced hearing loss, and OTO-6XX, which focuses on hair cell regeneration for severe hearing loss. Otonomy employs a proprietary formulation platform that enables sustained drug delivery from a single administration, enhancing treatment options for various ear-related conditions. The company also has strategic collaborations for gene therapy aimed at congenital hearing loss. Founded in 2008, Otonomy continues to lead advancements in otology through innovation and research.

Conjur offers a DevOps security software platform that helps organizations secure their cloud environments while automating infrastructure processes. The platform focuses on identity and access management, enabling enterprises to identify, authorize, and audit all service and user identities across various systems, including cloud services, virtual machines, and containers. By addressing operational, compliance, and security challenges, Conjur allows customers to protect sensitive IT systems and monitor access in real-time. The software enforces security policies, reduces vulnerability points, and generates detailed activity reports for compliance and security audits. As organizations increasingly adopt cloud computing, Conjur provides essential tools for security-conscious enterprises to deploy sensitive workloads confidently. Its notable clientele includes companies such as Discovery Communications, AOL, and Cisco. Conjur is backed by seed funding from investment firms like Avalon Partners and Amplify Partners.

Happy Cloud, Inc. is a technology company that specializes in an on-demand cloud-based gaming platform, enabling users to access games without the lengthy download and installation processes typical of traditional gaming. Founded in 2009 and headquartered in New York, with an additional office in Beit Shemesh, Israel, the company utilizes patent-pending technology that pre-installs and pre-packages games on its network. This innovative approach eliminates the need for server-side rendering and video streaming, ensuring a seamless gaming experience without lag, akin to playing from a physical disc. Happy Cloud's platform is designed for scalability and efficiency, allowing gamers to enjoy immediate access to a wide range of titles while bypassing the complexities of source code integration.

Cloudant is a provider of distributed database-as-a-service (DBaaS) that enables developers of web and mobile applications to concentrate on product development rather than database management and scaling. Founded in 2008 in Cambridge, Massachusetts, by three MIT physicists, Cloudant emerged from their need for improved tools to handle large data sets from the Large Hadron Collider. The company built a globally scalable, fault-tolerant data layer using Apache CouchDB, catering to the needs of fast-growing applications. Cloudant now manages and serves operational data for thousands of developers and hundreds of customers worldwide, offering robust data tools for loading, storing, analyzing, and distributing application data.

Nanigans is a Boston-based company that specializes in advertising automation software, designed to support in-house performance marketing teams. As a Software-as-a-Service provider, Nanigans offers a platform that features programmatic media buying, predictive revenue optimization, and real-time business intelligence. This comprehensive approach allows clients to enhance their advertising strategies and optimize revenue generation across various digital channels. In addition to its headquarters in Boston, Nanigans has established offices in New York, San Francisco, Seattle, London, Sydney, and Singapore, reflecting its global reach and commitment to serving a diverse client base.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Proximal Data specializes in server-side caching solutions tailored for virtualized environments. Its flagship product, AutoCache, enhances virtual machine density by alleviating I/O bottlenecks through adaptive I/O caching. This software, when used in conjunction with PCIe flash cards or SSDs from strategic partners, substantially boosts the efficiency and performance of virtualized servers. Proximal Data's solutions facilitate seamless IT operations, supporting the deployment of virtual server infrastructures without disruption.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

LoopIt is an online shopping platform that enhances the shopping experience by facilitating one-on-one conversations between users and their friends or experts. By connecting individuals for reviews and opinions throughout the entire purchasing journey—from product discovery to the point of purchase and beyond—LoopIt aims to make online shopping more enjoyable and interactive. The company focuses on building a supportive community where users can share their insights and experiences, helping others make informed decisions while also receiving valuable advice.

Cheezburger, Inc. is a Seattle-based company that operates a network of social humor websites, including popular platforms such as I Can Has Cheezburger, FAIL Blog, Know Your Meme, and Memebase. Founded in September 2007 by Ben Huh and Eric Nakagawa, the company specializes in providing social humor and entertainment content, allowing users to view, create, and remix memes, images, and videos. In addition to its extensive digital humor offerings, Cheezburger also provides advertising services to generate revenue. The company has published several books that compile humorous content from its platforms, further extending its brand into print media. Cheezburger operates as a subsidiary of Literally Media.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

Kaltura Inc. is a video platform provider serving a diverse range of sectors, including enterprises, media companies, service providers, and educational institutions. Founded in 2006 and based in New York, the company offers a comprehensive Video Experience Cloud that includes live, real-time, and on-demand video products. Its solutions encompass a variety of applications such as corporate training, video marketing, and virtual classroom environments, with specialized services tailored for educational and media sectors. Kaltura's platform supports multiple deployment options, including Software-as-a-Service and on-premise solutions, catering to a global clientele that engages hundreds of millions of viewers across various contexts, including communication, collaboration, and entertainment. The company primarily generates revenue from its Enterprise, Education, and Technology segment, with a significant portion coming from the United States.

Pingup is an online booking platform that facilitates real-time scheduling for local businesses across the United States. By offering a mobile API, Pingup allows directories and local listings providers to integrate a "book it now" feature, enhancing the convenience for mobile consumers. The platform supports over 30,000 properties in more than 200 business categories, continuously expanding its network by adding thousands of new businesses each month. Headquartered in Boston’s Innovation District, Pingup aims to streamline the appointment scheduling process, enabling consumers to easily book services through popular websites and mobile applications.

Proximal Data specializes in server-side caching solutions tailored for virtualized environments. Its flagship product, AutoCache, enhances virtual machine density by alleviating I/O bottlenecks through adaptive I/O caching. This software, when used in conjunction with PCIe flash cards or SSDs from strategic partners, substantially boosts the efficiency and performance of virtualized servers. Proximal Data's solutions facilitate seamless IT operations, supporting the deployment of virtual server infrastructures without disruption.

Selectable Media Inc. specializes in video advertising solutions tailored for brands and publishers. The company offers a range of services, including Selectable Value Exchange, which allows audiences to access content and services in return for interacting with brand advertisements. It also provides Selectable Sponsored Stories that distribute branded video content in contextually relevant environments. For publishers, Selectable Media's offerings, such as Content-Unlock and Value Exchange, facilitate consumer access to content by engaging with advertising or subscriptions. The company's partnerships span various sectors, including newspapers, magazines, mobile games, and Wi-Fi providers in public spaces. By collaborating with content providers across multiple devices, Selectable Media enables users to unlock digital content and services through brand interaction. Established in 2005 and based in New York, Selectable Media was formerly known as Nabbr.com Corp. and rebranded in 2007. As of December 31, 2014, it operates as a subsidiary of Meredith Corporation.

Shelby TV is a platform designed to enhance the discovery and enjoyment of web videos. Through its app, available in the App Store, Shelby TV curates a personalized channel of videos sourced from popular platforms such as YouTube, Vimeo, Hulu, and others, as well as content shared by users on social networks like Twitter, Tumblr, and Facebook. The service utilizes user preferences to refine and improve its video recommendations over time, ensuring that users receive tailored content that aligns with their interests. By combining various sources and leveraging social sharing, Shelby TV aims to deliver an engaging video entertainment experience.

Kinvey, Inc. offers a mobile backend as a service (mBaaS) platform designed to simplify the development of cloud backends for mobile, tablet, and web applications. Established in 2008 and based in Boston, Massachusetts, Kinvey enables developers to focus exclusively on application development without the burden of managing server infrastructure or integrating various cloud services. The platform provides automated API generation, allowing developers to seamlessly connect their applications to backend services. Kinvey's solutions cater to a diverse range of industries, including healthcare, finance, utilities, and media, facilitating features such as data storage, user management, push notifications, and analytics. As of June 2017, Kinvey operates as a subsidiary of Progress Software Corporation.

Backupify, now part of Datto, specializes in cloud-to-cloud backup solutions designed to safeguard businesses' cloud-based data. The company's software offers features such as data retention and protection against ransomware and service outages, ensuring that critical business information remains accessible and secure. Backupify caters to IT professionals by providing the necessary tools to prevent data loss due to user errors, external attacks, and other disruptions, thereby enabling both end users and administrators to operate with confidence in their data's safety.

Byliner is a digital publishing company based in San Francisco that focuses on delivering concise literary works, referred to as e-shorts, which are designed to be read in two hours or less. The company collaborates directly with writers to provide a platform for their stories, allowing readers to purchase individual pieces through major digital bookstores. Additionally, Byliner offers a subscription service that grants members access to an exclusive community of authors, featuring a collection of premium content, including rare and previously unseen stories. Through its offerings, Byliner aims to enhance readers' personal skill development and effective self-expression by providing insightful articles on various topics, including books and communication.

Cardeas Pharma is focused on developing a novel antibiotic formulation that combines two drugs to effectively target highly resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, as well as carbapenem-resistant Enterobacteriaceae. This formulation is also effective against biofilms and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The antibiotics are delivered through a single-patient use nebulizer that produces small, uniform aerosol droplets, allowing for targeted delivery to the small airways and alveoli. By integrating this innovative antibiotic formulation with advanced drug-delivery technology, Cardeas Pharma aims to improve clinical outcomes for patients suffering from serious, hospital-acquired respiratory infections.